Photo of Steven Daroci

Steven Daroci

Partner, Seeger Weiss

973-639-9100sdaroci@seegerweiss.com

55 Challenger Road
Ridgefield Park, NJ 07660

View Firm Biography

Seeger Weiss partner Steven Daroci is a seasoned litigator known for his expertise in drug injury, commercial litigation, product liability, and more. Since joining Seeger Weiss in 2022, Daroci rose swiftly through the ranks and was promoted to partner in 2024. His impactful presence in high-profile MDLs underscores his skill and commitment to representing injured plaintiffs.

Daroci is a critical part of the team supporting Seeger Weiss partner and co-lead counsel David Buchanan, who is at the forefront of a crucial legal battle in the recently consolidated Insulin Pricing MDL. Daroci and the Seeger Weiss team represent more than a dozen state and local governments and other self-funded payers who have filed lawsuits against insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi, as well as pharmacy benefit managers (PBMs) CVS Caremark, Express Scripts, and OptumRx, over allegations that they colluded to aggressively inflate the price of insulin and other diabetes medications. Seeger Weiss represents several government entities and other organizations with self-funded health plans that filed similar lawsuits centralized before Judge Martinotti in the District of New Jersey.

Lawdragon Honors

Honor Year Practice
The 2026 Lawdragon 500 Leading Lawyers in America 2026 Plaintiff Mass Torts Litigation
The 2025 Lawdragon 500 X – The Next Generation 2025 Plaintiff Product Liability, Class Actions
The 2025 Lawdragon 500 Leading Plaintiff Financial Lawyers 2025 Complex Litigation, Product Liability
The 2025 Lawdragon 500 Leading Plaintiff Consumer Lawyers 2025 Drug Injury, Product Liability
The 2025 Lawdragon 500 Leading Lawyers in America 2025 Plaintiff Mass Torts Litigation
The 2024 Lawdragon 500 Leading Plaintiff Financial Lawyers 2024 Complex Litigation, Product Liability
The 2024 Lawdragon 500 X – The Next Generation 2024 Plaintiff Product Liability, Class Actions

Daroci played a key role in In re: Elmiron (Pentosan Polysulfate Sodium) Products Liability Litigation. In this case, Daroci represented women who took the bladder cyst medication Elmiron and, as a result of using the drug, suffered serious eye injuries such as pigmentary maculopathy. The case alleges that the pharmaceutical company Johnson & Johnson failed to tell doctors and patients about the risk of permanent vision injury while taking Elmiron. Daroci supported Seeger Weiss partner and co-lead counsel, Parvin Aminolroaya, in negotiations that led to a confidential settlement on behalf of hundreds of plaintiffs impacted by Johnson & Johnson’s misconduct.

Daroci represents a class of drivers in a federal class action against General Motors who allege GM hid defects in its trucks and SUVs, particularly in the Sensing and Diagnostic Module (SDM) system, impacting airbag and seatbelt functioning during crashes. Millions of General Motors trucks and SUVs placed occupants at risk of serious injury or death during a crash due to a defect in the Sensing and Diagnostic Module (SDM) system, which controls airbag and seatbelt functioning. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Daroci earned his law degree from Fordham University School of Law and his undergraduate degree in business administration from Georgetown University. Before moving to the plaintiffs’ bar, Daroci was a Partner at AmLaw 100 law firm Fox Rothschild, handling complex state and federal litigation at both trial and appellate levels.